Shares of Ventas, Inc. (NYSE:VTR – Get Free Report) have been given an average rating of “Moderate Buy” by the nineteen brokerages that are presently covering the company, Marketbeat.com reports. Five equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $96.1667.
VTR has been the topic of several research analyst reports. JPMorgan Chase & Co. boosted their price target on shares of Ventas from $93.00 to $94.00 and gave the stock an “overweight” rating in a research note on Monday, May 11th. The Goldman Sachs Group restated a “buy” rating and set a $110.00 price objective on shares of Ventas in a research report on Tuesday, May 19th. Weiss Ratings cut Ventas from a “buy (b-)” rating to a “hold (c+)” rating in a report on Wednesday. UBS Group boosted their target price on Ventas from $85.00 to $93.00 and gave the stock a “neutral” rating in a research report on Monday, May 4th. Finally, Barclays assumed coverage on Ventas in a report on Tuesday. They set an “equal weight” rating and a $99.00 price target for the company.
Read Our Latest Stock Analysis on VTR
Insiders Place Their Bets
Institutional Trading of Ventas
A number of large investors have recently made changes to their positions in VTR. Dynamic Wealth Strategies LLC bought a new stake in Ventas in the first quarter worth $25,000. GoalVest Advisory LLC bought a new position in Ventas during the fourth quarter valued at $26,000. Wiser Advisor Group LLC purchased a new stake in shares of Ventas in the third quarter valued at $27,000. IFC & Insurance Marketing Inc. purchased a new stake in shares of Ventas in the fourth quarter valued at $30,000. Finally, Elyxium Wealth LLC bought a new stake in shares of Ventas in the 4th quarter worth about $33,000. 94.18% of the stock is currently owned by institutional investors.
Ventas Price Performance
VTR traded down $1.13 during trading on Monday, reaching $90.61. 3,084,091 shares of the company traded hands, compared to its average volume of 4,040,328. The company has a market cap of $44.05 billion, a P/E ratio of 164.75, a PEG ratio of 1.97 and a beta of 0.70. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.25 and a current ratio of 0.25. Ventas has a 12-month low of $62.82 and a 12-month high of $94.60. The firm has a fifty day simple moving average of $86.61 and a 200 day simple moving average of $83.66.
Ventas (NYSE:VTR – Get Free Report) last released its earnings results on Monday, April 27th. The real estate investment trust reported $0.11 EPS for the quarter, missing the consensus estimate of $0.12 by ($0.01). Ventas had a return on equity of 2.09% and a net margin of 4.25%.The company had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.59 billion. During the same period last year, the firm posted $0.84 EPS. Ventas’s quarterly revenue was up 22.0% compared to the same quarter last year. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. On average, equities analysts forecast that Ventas will post 3.88 EPS for the current year.
Ventas Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Thursday, July 16th. Stockholders of record on Tuesday, June 30th will be given a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date is Tuesday, June 30th. Ventas’s dividend payout ratio is currently 378.18%.
Ventas Company Profile
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
Featured Articles
- Five stocks we like better than Ventas
- Power Struggle: Wolfspeed Sues Navitas Over AI Chips
- Why WD-40 Is Proving Great Businesses Never Go Out of Style
- Pushing the Edge: Super Micro Computer Reboots the AI Landscape
- MarketBeat Week in Review – 07/06 – 07/10
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
